Chronic adriamycin treatment impairs CGRP-mediated functions of meningeal sensory nerves

Adriamycin is a potent anthracycline-type antitumor agent, but it also exerts potentially serious side effects due to its cardiotoxic and neurotoxic propensity. Multiple impairments in sensory nerve functions have been recently reported in various rat models. The present experiments were initiated in an attempt to reveal adriamycin-induced changes in sensory effector functions of chemosensitive meningeal afferents.Meningeal blood flow was measured with laser Doppler flowmetry in the parietal dura mater of adult male Wistar rats.

Source: Neuropeptides - April 9, 2018 Category: Neuroscience Authors: Éva Deák, Judit Rosta, Krisztina Boros, Gyöngyi Kis, Péter Sántha, Karl Messlinger, Gábor Jancsó, Mária Dux Source Type: research